| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |